Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study was terminated in the United States. It is testing adverse Events of Fosigotifator for depression.
In United StatesThis study is completed in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.
In United StatesThis study is completed in the United States. It is testing KarXT for schizophrenia.
In United StatesThis study is completed in the United States and in Ukraine. It is testing KarXT for schizophrenia.
In United StatesThis study was withdrawn in the United States. It is testing Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy for treatment-resistant depression.
In United StatesThis study is completed in the United States. It is testing Safety and Efficacy of KarXT for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 for schizophrenia.
In United StatesThis study was terminated in the United States. It is testing clinical Utility of Antipsychotic Medication Levels for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing buprenorphine/Naloxone for Addiction.
In United StatesThis study is completed in the United States. It is testing Effect of AZD4041 on Respiratory Drive for Addiction.
In United StatesThis study was terminated in the United States. It is testing Effects Of PF-04457845 On BOLD fMRI for PTSD.
In United StatesThis study was terminated in the United States, in Japan, in Spain, .... It is testing Effects of RO6889450 (Ralmitaront) for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.